These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35311743)

  • 1. Malignant Pineal Parenchymal Tumors in Adults: A National Cancer Database Analysis.
    Chalif EJ; Murray RD; Mozaffari K; Chillakuru YR; Shim T; Monfared A; Sherman JH
    Neurosurgery; 2022 Jun; 90(6):807-815. PubMed ID: 35311743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade.
    Lu VM; Luther EM; Eichberg DG; Morell AA; Shah AH; Komotar RJ; Ivan ME
    J Neurooncol; 2021 Nov; 155(2):165-172. PubMed ID: 34606044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome.
    Raleigh DR; Solomon DA; Lloyd SA; Lazar A; Garcia MA; Sneed PK; Clarke JL; McDermott MW; Berger MS; Tihan T; Haas-Kogan DA
    Neuro Oncol; 2017 Jan; 19(1):78-88. PubMed ID: 27282397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation.
    Ito T; Kanno H; Sato K; Oikawa M; Ozaki Y; Nakamura H; Terasaka S; Kobayashi H; Houkin K; Hatanaka K; Murata J; Tanaka S
    World Neurosurg; 2014; 81(5-6):783-9. PubMed ID: 23396072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary pineal tumors - Unraveling histological challenges and certain clinical myths.
    Verma A; Epari S; Bakiratharajan D; Sahay A; Goel N; Chinnaswamy G; Shetty P; Moiyadi A; Goel A; Gupta T; Jalali R
    Neurol India; 2019; 67(2):491-502. PubMed ID: 31085866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Features of Pineal Parenchymal Tumors of Intermediate Differentiation (PPTID): A Single-Institution Series.
    Kunigelis KE; Kleinschmidt-DeMasters BK; Youssef AS; Lillehei KO; Ormond DR
    World Neurosurg; 2021 Nov; 155():e229-e235. PubMed ID: 34418607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study.
    Fèvre-Montange M; Vasiljevic A; Frappaz D; Champier J; Szathmari A; Aubriot Lorton MH; Chapon F; Coulon A; Quintin Roué I; Delisle MB; Figarella-Branger D; Laquerrière A; Miquel C; Michiels JF; Péoch M; Polivka M; Fauchon F; Jouvet A
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):87-94. PubMed ID: 21696422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Care and Age-Specific Impact of Extent of Resection and Adjuvant Radiotherapy in Pediatric Pineoblastoma.
    Jin MC; Prolo LM; Wu A; Azad TD; Shi S; Rodrigues AJ; Soltys SG; Pollom EL; Li G; Hiniker SM; Grant GA
    Neurosurgery; 2020 May; 86(5):E426-E435. PubMed ID: 32110805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pineal Parenchymal Tumor of Intermediate Differentiation (PPTID) and Papillary Tumor of Pineal Region (PTPR): A Review.
    Sadashiva N; Deora H; Arumalla K; Rao S; Saini J; Shukla D; Santosh V
    Neurol India; 2021; 69(5):1153-1164. PubMed ID: 34747779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group.
    Yamashita S; Takeshima H; Hata N; Uchida H; Shinojima N; Yokogami K; Nakano Y; Sakata K; Fudaba H; Enomoto T; Nakahara Y; Ujifuku K; Sugawara K; Iwaki T; Sangatsuda Y; Yoshimoto K; Hanaya R; Mukasa A; Suzuki K; Yamamoto J; Negoto T; Nakamura H; Momii Y; Fujiki M; Abe H; Masuoka J; Abe T; Matsuo T; Ishiuchi S;
    J Neurooncol; 2023 Apr; 162(2):425-433. PubMed ID: 37052748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: An individual patient data analysis.
    Mallick S; Benson R; Rath GK
    Radiother Oncol; 2016 Nov; 121(2):204-208. PubMed ID: 27865543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pineal parenchymal tumours of intermediate differentiation - An evidence-based review of a new pathological entity.
    Amato-Watkins AC; Lammie A; Hayhurst C; Leach P
    Br J Neurosurg; 2016; 30(1):11-5. PubMed ID: 26571134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and Malignant Transformation of Pineal Parenchymal Tumors: A 30-Year Retrospective Analysis in a Single-Institution.
    Park TH; Kim SK; Phi JH; Park CK; Kim YH; Paek SH; Lee CH; Park SH; Koh EJ
    Brain Tumor Res Treat; 2023 Oct; 11(4):254-265. PubMed ID: 37953449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and associated predictors for patients with pineoblastoma or pineal parenchymal tumors of intermediate differentiation older than 3 years: Insights from the National Cancer Database.
    Kerezoudis P; Yolcu YU; Laack NN; Ruff MW; Khatua S; Daniels DJ; Burns TC; Kizilbash SH
    Neurooncol Adv; 2022; 4(1):vdac057. PubMed ID: 35611271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pineal parenchymal tumor of intermediate differentiation: a systematic review and contemporary management of 389 cases reported during the last two decades.
    Takase H; Tanoshima R; Singla N; Nakamura Y; Yamamoto T
    Neurosurg Rev; 2022 Apr; 45(2):1135-1155. PubMed ID: 34668090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis.
    Webb M; Johnson DR; Mahajan A; Brown P; Neth B; Kizilbash SH; Sener U
    J Neurooncol; 2022 Nov; 160(2):527-534. PubMed ID: 36301435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology of tumors of the pineal region.
    Fèvre-Montange M; Vasiljevic A; Champier J; Jouvet A
    Future Oncol; 2010 May; 6(5):791-809. PubMed ID: 20465391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003--a single institution's experience.
    Stoiber EM; Schaible B; Herfarth K; Schulz-Ertner D; Huber PE; Debus J; Oertel S
    Radiat Oncol; 2010 Dec; 5():122. PubMed ID: 21184689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategy for pineal parenchymal tumor of intermediate differentiation (PPTID): case report of PPTID with malignant transformation to pineocytoma with leptomeningeal dissemination 6 years after surgery.
    Bando T; Ueno Y; Shinoda N; Imai Y; Ichikawa K; Kuramoto Y; Kuroyama T; Shimo D; Mikami K; Hori S; Matsumoto M; Hirai O
    J Neurosurg; 2019 Jun; 130(6):2009-2015. PubMed ID: 30028263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pineal parenchymal tumors of intermediate differentiation in adults: case report and literature review.
    Pusztaszeri M; Pica A; Janzer R
    Neuropathology; 2006 Apr; 26(2):153-7. PubMed ID: 16708548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.